The Australian Competition and Consumer Commission is investigating competition concerns about Apple’s refusal to allow third party access to the near-field communication chip that allows iPhone users to make ‘tap and go’ payments through Apple Pay.
A proposed alliance between Qantas and Japan Airlines has failed to take flight after the Australian Competition and Consumer Commission said the coordination of flights between Australia, New Zealand and Japan could cause ticket prices to soar.
Approximately 1,000 investors of collapsed stockbroker Halifax Investment Services have challenged a court decision concerning the date of the realisation of their investments which decreased the amounts they could recoup from the company’s liquidation.
Freight forwarding company Mondiale has filed a lawsuit against Wisetech Global alleging the logistics software firm breached competition law by misusing its substantial market power.
A PwC partner who the ATO claims was assigned to work on a matter for meat processing company JBS to bring a “cloak of legal privilege” kept a supporting role on the brief despite the company CFO’s dissatisfaction, a court has heard.
A law firm may have exerted unfair or illegitimate pressure on a sacked solicitor when it told her to accept an offer to settle her adverse action case or risk referral to the legal watchdog, a judge has found.
Insurance giant Lloyd’s has rejected what it calls an “incomprehensible” class action pleading by Australian businesses that argue its business interruption policies should have indemnified them for losses stemming from COVID-19 lockdowns.
Franchisees of Hog’s Breath Cafe restaurant chain have been accused of “crying poor” by claiming COVID-19 robbed their restaurants of the cash flow required to pay security for costs in a class action launched against master franchisor HBCA.
Cruise operator Carnival has lost its bid to exclude US and UK passengers from a class action over the 2020 Ruby Princess COVID-19 outbreak, with a judge finding the Federal Court was not a “clearly inappropriate forum” to hear the dispute.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.